Back to results
RecruitingN/A

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

NCT06536881

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sibley Memorial Hospital

Washington D.C., District of Columbia, United States

Contact

Jennifer Sheng, MD

202-537-4000jsheng7@jhmi.edu
View on ClinicalTrials.gov
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming — TrialFind